Literature DB >> 8942891

Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure.

D H Shin1, B A Hughes, M S Song, C Kim, K J Yang, M I Shah, M S Juzych, T Obertynski.   

Abstract

PURPOSE: The prerequisite for selective use of adjunctive mitomycin C (MMC) in primary glaucoma triple procedure (PGTP) is a better understanding of the prognostic factors. Therefore, the authors carried out the current study on the outcome of PGTP with and without adjunctive MMC to determine the prognostic factors for filtration failure of PGTP.
METHODS: The study patients consisted of 174 consecutive primary open-angle glaucoma (POAG) patients undergoing PGTP. They were assigned randomly to either no adjunctive MMC (93 eyes of 93 patients) or adjunctive subconjunctival MMC (81 eyes of 81 patients) during the PGTP. After surgery, the patients were examined at regular intervals for visual acuity, intraocular pressure (IOP) control, medical therapy requirements, and complications. Filtration failure was determined according to two different criteria: (1) a less stringent set of criteria (criterion I) and (2) a more stringent set of criteria (criterion II).
RESULTS: There were no statistically significant differences between the groups with and without adjunctive MMC with respect to postoperative IOP, number of medications, and visual acuity outcome during mean follow-up (+/- standard deviation) of 25.1 +/- 5.5 months (P > 0.05 for each). However, there were prognostic factors for filtration failure in the control group but not in the MMC group. Black race, diabetes mellitus, preoperative IOP greater than or equal to 20 mmHg, and number of preoperative medications greater than two were found to be significant prognostic factors for filtration failure by criterion I. Black race, preoperative IOP greater than or equal to 20 mmHg and number of preoperative medications greater than 1 were significant prognostic factors for filtration failure by criterion II.
CONCLUSION: There was no statistically significant difference in the overall outcome of PGTP between control and MMC groups of nonselected patients with primary open-angle glaucoma. Black race, diabetes mellitus (by criterion I only), preoperative IOP greater than or equal to 20 mmHg, and number of preoperative medications greater than 2 (by criterion I) or greater than 1 (by criterion II) were found to be significant independent prognostic factors for filtration failure of PGTP without adjunctive MMC but no with adjunctive MMC. The use of adjunctive subconjunctival MMC in PGTP may have to be selective, primarily in those patients with primary open-angle glaucoma with one or more of the prognostic factors for filtration failure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942891     DOI: 10.1016/s0161-6420(96)30406-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population.

Authors:  Victor Koh; David Chen; Cecilia Maria Aquino; Joel Aduan; Chelvin Sng; Loon Seng Chee; Paul Chew
Journal:  Jpn J Ophthalmol       Date:  2017-02-10       Impact factor: 2.447

2.  Sponge delivery variables and tissue levels of 5-fluorouracil.

Authors:  M R Wilkins; N L Occleston; A Kotecha; L Waters; P T Khaw
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

3.  Long term results of glaucoma surgery among participants in an east African population survey.

Authors:  H A Quigley; R R Buhrmann; S K West; I Isseme; M Scudder; M S Oliva
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

4.  Observational Outcomes of Initial Trabeculectomy With Mitomycin C in Patients of African Descent vs Patients of European Descent: Five-Year Results.

Authors:  Andrew H Nguyen; Nima Fatehi; Pablo Romero; Arezoo Miraftabi; EunAh Kim; Esteban Morales; JoAnn Giaconi; Anne L Coleman; Simon K Law; Joseph Caprioli; Kouros Nouri-Mahdavi
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

5.  Glaucoma Treatment Outcomes in Open Angle Glaucoma Patients of African Descent.

Authors:  Brent Siesky; Alon Harris; Aditya Belamkar; Ryan Zukerman; Avery Horn; Alice Verticchio Vercellin; Kristen A Mendoza; Paul A Sidoti; Francesco Oddone
Journal:  J Glaucoma       Date:  2022-03-29       Impact factor: 2.290

6.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.

Authors:  David C Musch; Brenda W Gillespie; Paul R Lichter; Leslie M Niziol; Nancy K Janz
Journal:  Ophthalmology       Date:  2008-11-18       Impact factor: 12.079

8.  Visual Field Outcomes in the Tube Versus Trabeculectomy Study.

Authors:  Swarup S Swaminathan; Alessandro A Jammal; Helen L Kornmann; Philip P Chen; William J Feuer; Felipe A Medeiros; Steven J Gedde
Journal:  Ophthalmology       Date:  2020-03-04       Impact factor: 14.277

9.  Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.

Authors:  Gina M Martorana; Jamie L Schaefer; Monica A Levine; Zachary L Lukowski; Jeff Min; Craig A Meyers; Gregory S Schultz; Mark B Sherwood
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

10.  LONG TERM OUTCOMES OF AUGMENTED TRABECULECTOMY WITH 5-FLUOROURACIL IN NIGERIA.

Authors:  O O Olawoye; A O Ashaye
Journal:  J West Afr Coll Surg       Date:  2017 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.